James Pearson
Concepts (285)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heat Stress Disorders | 7 | 2023 | 84 | 2.620 |
Why?
| | Skin Temperature | 6 | 2026 | 36 | 2.530 |
Why?
| | Lower Body Negative Pressure | 7 | 2024 | 26 | 2.000 |
Why?
| | Hemodynamics | 9 | 2026 | 1118 | 1.990 |
Why?
| | Arterial Pressure | 9 | 2026 | 134 | 1.930 |
Why?
| | Body Temperature | 6 | 2026 | 227 | 1.890 |
Why?
| | Exercise | 12 | 2026 | 2205 | 1.780 |
Why?
| | Hemorrhage | 6 | 2024 | 822 | 1.660 |
Why?
| | Cold Temperature | 4 | 2026 | 206 | 1.510 |
Why?
| | Body Temperature Regulation | 8 | 2026 | 105 | 1.360 |
Why?
| | Skin | 4 | 2024 | 754 | 1.350 |
Why?
| | Heat-Shock Response | 7 | 2023 | 77 | 1.260 |
Why?
| | Regional Blood Flow | 11 | 2026 | 514 | 1.060 |
Why?
| | Myocardium | 4 | 2026 | 935 | 1.000 |
Why?
| | Sweating | 6 | 2017 | 43 | 0.770 |
Why?
| | Fever | 6 | 2017 | 319 | 0.760 |
Why?
| | Muscle, Skeletal | 4 | 2026 | 1791 | 0.700 |
Why?
| | Skin Transplantation | 3 | 2017 | 85 | 0.690 |
Why?
| | Sympathetic Nervous System | 3 | 2019 | 181 | 0.630 |
Why?
| | Equilibrative Nucleoside Transport Proteins | 1 | 2019 | 1 | 0.620 |
Why?
| | Diastole | 2 | 2019 | 146 | 0.620 |
Why?
| | Hypoxia | 6 | 2016 | 1199 | 0.610 |
Why?
| | Microcirculation | 3 | 2016 | 142 | 0.610 |
Why?
| | Hot Temperature | 4 | 2017 | 396 | 0.610 |
Why?
| | Myocytes, Cardiac | 2 | 2025 | 546 | 0.590 |
Why?
| | Oxidative Stress | 4 | 2025 | 1359 | 0.590 |
Why?
| | Exercise Tolerance | 2 | 2018 | 283 | 0.570 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2019 | 139 | 0.560 |
Why?
| | Dehydration | 4 | 2013 | 58 | 0.560 |
Why?
| | Syncope | 4 | 2023 | 56 | 0.560 |
Why?
| | Cerebrovascular Circulation | 6 | 2020 | 290 | 0.540 |
Why?
| | Burns | 4 | 2017 | 374 | 0.520 |
Why?
| | Serotonin | 1 | 2019 | 298 | 0.510 |
Why?
| | Reflex | 1 | 2017 | 70 | 0.500 |
Why?
| | Thermotolerance | 1 | 2017 | 8 | 0.500 |
Why?
| | Methacholine Chloride | 1 | 2017 | 51 | 0.500 |
Why?
| | Blood Pressure | 6 | 2026 | 1782 | 0.490 |
Why?
| | Rest | 3 | 2013 | 126 | 0.480 |
Why?
| | Prediabetic State | 1 | 2019 | 250 | 0.480 |
Why?
| | Young Adult | 16 | 2026 | 14251 | 0.440 |
Why?
| | Central Nervous System | 1 | 2017 | 282 | 0.430 |
Why?
| | Endothelium, Vascular | 2 | 2019 | 956 | 0.430 |
Why?
| | Male | 42 | 2026 | 73003 | 0.420 |
Why?
| | Leg | 3 | 2013 | 242 | 0.420 |
Why?
| | Oxygen | 3 | 2015 | 981 | 0.390 |
Why?
| | Drosophila melanogaster | 1 | 2015 | 239 | 0.390 |
Why?
| | Rats, Wistar | 3 | 2019 | 450 | 0.380 |
Why?
| | Synchrotrons | 4 | 2020 | 12 | 0.380 |
Why?
| | Muscle Contraction | 2 | 2010 | 429 | 0.330 |
Why?
| | Acetylcholine | 4 | 2020 | 209 | 0.330 |
Why?
| | Adult | 23 | 2026 | 40872 | 0.330 |
Why?
| | Blood Flow Velocity | 8 | 2017 | 421 | 0.310 |
Why?
| | Pulmonary Artery | 3 | 2014 | 1129 | 0.300 |
Why?
| | Coronary Artery Disease | 1 | 2016 | 750 | 0.300 |
Why?
| | Heart Rate | 4 | 2023 | 856 | 0.300 |
Why?
| | rho-Associated Kinases | 2 | 2025 | 82 | 0.300 |
Why?
| | Inflammation | 2 | 2022 | 2883 | 0.290 |
Why?
| | Intestines | 1 | 2012 | 354 | 0.290 |
Why?
| | Female | 27 | 2026 | 79035 | 0.280 |
Why?
| | Oxygen Consumption | 4 | 2018 | 719 | 0.280 |
Why?
| | Myocardial Contraction | 2 | 2025 | 293 | 0.280 |
Why?
| | Aging | 3 | 2026 | 1973 | 0.270 |
Why?
| | Insulin Resistance | 1 | 2016 | 1244 | 0.260 |
Why?
| | Time Factors | 8 | 2026 | 7133 | 0.260 |
Why?
| | Homeobox Protein Nkx-2.5 | 2 | 2017 | 6 | 0.250 |
Why?
| | Animals | 22 | 2026 | 38097 | 0.240 |
Why?
| | Angiography | 5 | 2014 | 208 | 0.240 |
Why?
| | Humans | 38 | 2026 | 145763 | 0.240 |
Why?
| | Anaerobic Threshold | 1 | 2026 | 28 | 0.240 |
Why?
| | Hyperthermia, Induced | 3 | 2017 | 120 | 0.240 |
Why?
| | Ventricular Function, Left | 4 | 2016 | 544 | 0.240 |
Why?
| | Lactic Acid | 2 | 2026 | 295 | 0.240 |
Why?
| | Mesenteric Arteries | 1 | 2025 | 17 | 0.230 |
Why?
| | Muscle Tonus | 1 | 2025 | 24 | 0.230 |
Why?
| | Creatine Kinase | 1 | 2025 | 72 | 0.230 |
Why?
| | Hydrolases | 1 | 2025 | 40 | 0.230 |
Why?
| | Sphingosine | 1 | 2025 | 47 | 0.220 |
Why?
| | Pressoreceptors | 2 | 2015 | 19 | 0.220 |
Why?
| | Heart | 3 | 2019 | 626 | 0.220 |
Why?
| | Lysophospholipids | 1 | 2025 | 80 | 0.220 |
Why?
| | Heart Defects, Congenital | 3 | 2018 | 910 | 0.220 |
Why?
| | Vasodilation | 4 | 2019 | 521 | 0.220 |
Why?
| | Adenosine Triphosphate | 3 | 2013 | 500 | 0.210 |
Why?
| | Physical Endurance | 1 | 2026 | 279 | 0.210 |
Why?
| | Acclimatization | 2 | 2017 | 170 | 0.210 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2025 | 143 | 0.210 |
Why?
| | Running | 1 | 2026 | 233 | 0.200 |
Why?
| | Vagus Nerve Stimulation | 2 | 2020 | 28 | 0.190 |
Why?
| | Heart Ventricles | 2 | 2019 | 756 | 0.190 |
Why?
| | Hydrogen Peroxide | 2 | 2025 | 335 | 0.180 |
Why?
| | Pulmonary Circulation | 3 | 2011 | 430 | 0.180 |
Why?
| | Disease Models, Animal | 5 | 2026 | 4568 | 0.180 |
Why?
| | Rats | 5 | 2019 | 5585 | 0.180 |
Why?
| | Interleukin-13 | 1 | 2022 | 146 | 0.170 |
Why?
| | Afferent Pathways | 1 | 2020 | 46 | 0.160 |
Why?
| | Lung | 7 | 2022 | 4116 | 0.160 |
Why?
| | Ventricular Dysfunction, Left | 2 | 2026 | 394 | 0.160 |
Why?
| | Body Surface Area | 2 | 2017 | 34 | 0.150 |
Why?
| | Microdialysis | 1 | 2019 | 56 | 0.150 |
Why?
| | Stroke Volume | 2 | 2015 | 655 | 0.150 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 2019 | 23 | 0.150 |
Why?
| | Hydroxyindoleacetic Acid | 1 | 2019 | 24 | 0.150 |
Why?
| | Guanylate Cyclase | 1 | 2019 | 38 | 0.150 |
Why?
| | Connectin | 1 | 2019 | 42 | 0.150 |
Why?
| | Multienzyme Complexes | 1 | 2019 | 65 | 0.150 |
Why?
| | Positive-Pressure Respiration | 1 | 2020 | 115 | 0.150 |
Why?
| | Bicycling | 2 | 2018 | 117 | 0.150 |
Why?
| | Myosins | 1 | 2019 | 132 | 0.150 |
Why?
| | Superoxides | 1 | 2019 | 198 | 0.140 |
Why?
| | Central Venous Pressure | 2 | 2015 | 17 | 0.140 |
Why?
| | Middle Cerebral Artery | 3 | 2013 | 56 | 0.140 |
Why?
| | Actin Cytoskeleton | 1 | 2019 | 103 | 0.140 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2019 | 203 | 0.140 |
Why?
| | Mitochondria | 1 | 2025 | 992 | 0.140 |
Why?
| | Vagus Nerve | 1 | 2019 | 92 | 0.140 |
Why?
| | Quinolines | 1 | 2019 | 190 | 0.140 |
Why?
| | Mice, Inbred C57BL | 6 | 2026 | 5992 | 0.130 |
Why?
| | Random Allocation | 1 | 2018 | 365 | 0.130 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2018 | 70 | 0.130 |
Why?
| | T-Lymphocytes | 1 | 2025 | 1997 | 0.130 |
Why?
| | Case-Control Studies | 2 | 2017 | 3634 | 0.130 |
Why?
| | Infusions, Subcutaneous | 1 | 2017 | 23 | 0.120 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2022 | 420 | 0.120 |
Why?
| | Mice, Knockout | 4 | 2026 | 3130 | 0.120 |
Why?
| | Nitric Oxide | 2 | 2019 | 892 | 0.120 |
Why?
| | Gases | 1 | 2016 | 46 | 0.120 |
Why?
| | Cytokines | 2 | 2025 | 2069 | 0.120 |
Why?
| | Pulse Wave Analysis | 1 | 2017 | 267 | 0.120 |
Why?
| | ERG1 Potassium Channel | 1 | 2016 | 6 | 0.120 |
Why?
| | Vasoconstriction | 5 | 2025 | 216 | 0.120 |
Why?
| | Renal Circulation | 1 | 2016 | 75 | 0.120 |
Why?
| | Point Mutation | 1 | 2017 | 241 | 0.120 |
Why?
| | Urea | 1 | 2016 | 85 | 0.120 |
Why?
| | Survivors | 2 | 2017 | 523 | 0.120 |
Why?
| | Brain | 3 | 2020 | 2969 | 0.120 |
Why?
| | Mice | 9 | 2026 | 18355 | 0.120 |
Why?
| | Hyperventilation | 1 | 2015 | 15 | 0.110 |
Why?
| | Iodine | 2 | 2014 | 27 | 0.110 |
Why?
| | Coronary Circulation | 1 | 2016 | 134 | 0.110 |
Why?
| | Hyperemia | 1 | 2016 | 49 | 0.110 |
Why?
| | Posture | 1 | 2017 | 197 | 0.110 |
Why?
| | Respiratory Physiological Phenomena | 1 | 2015 | 35 | 0.110 |
Why?
| | Homeostasis | 2 | 2017 | 644 | 0.110 |
Why?
| | Phosphorylation | 1 | 2019 | 1708 | 0.110 |
Why?
| | Adaptation, Physiological | 2 | 2017 | 560 | 0.110 |
Why?
| | Reference Values | 1 | 2017 | 798 | 0.110 |
Why?
| | Wnt Signaling Pathway | 1 | 2017 | 212 | 0.110 |
Why?
| | Metformin | 1 | 2018 | 329 | 0.110 |
Why?
| | Metabolic Syndrome | 1 | 2018 | 361 | 0.110 |
Why?
| | Ventilation-Perfusion Ratio | 1 | 2014 | 11 | 0.110 |
Why?
| | Sweat | 1 | 2014 | 51 | 0.110 |
Why?
| | Injury Severity Score | 1 | 2017 | 599 | 0.100 |
Why?
| | Forearm | 1 | 2014 | 141 | 0.100 |
Why?
| | Arteries | 1 | 2016 | 261 | 0.100 |
Why?
| | Physical Fitness | 1 | 2015 | 207 | 0.100 |
Why?
| | Peptides | 1 | 2019 | 998 | 0.100 |
Why?
| | Adolescent | 4 | 2023 | 22573 | 0.100 |
Why?
| | Hypercapnia | 1 | 2013 | 53 | 0.100 |
Why?
| | Thermometers | 1 | 2012 | 6 | 0.090 |
Why?
| | Heart Failure | 1 | 2026 | 2326 | 0.090 |
Why?
| | Biological Evolution | 1 | 2016 | 468 | 0.090 |
Why?
| | Obesity | 1 | 2026 | 3118 | 0.090 |
Why?
| | Sweat Glands | 1 | 2012 | 5 | 0.090 |
Why?
| | Paper | 1 | 2012 | 9 | 0.090 |
Why?
| | Vascular Stiffness | 1 | 2017 | 487 | 0.090 |
Why?
| | Telemetry | 1 | 2012 | 40 | 0.090 |
Why?
| | Hot Flashes | 1 | 2013 | 92 | 0.090 |
Why?
| | Chronic Disease | 2 | 2016 | 1812 | 0.090 |
Why?
| | Animals, Newborn | 1 | 2014 | 896 | 0.090 |
Why?
| | Hemoglobins | 2 | 2012 | 386 | 0.090 |
Why?
| | Stress, Physiological | 1 | 2014 | 443 | 0.090 |
Why?
| | Cardiovascular System | 1 | 2013 | 139 | 0.090 |
Why?
| | Catheterization | 1 | 2012 | 184 | 0.080 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2012 | 92 | 0.080 |
Why?
| | Diagnostic Tests, Routine | 1 | 2012 | 107 | 0.080 |
Why?
| | Water-Electrolyte Balance | 1 | 2010 | 37 | 0.080 |
Why?
| | Oxyhemoglobins | 1 | 2010 | 28 | 0.080 |
Why?
| | Postmenopause | 1 | 2013 | 394 | 0.080 |
Why?
| | Nitrites | 1 | 2010 | 88 | 0.080 |
Why?
| | Cerebral Arteries | 2 | 2025 | 59 | 0.080 |
Why?
| | Epinephrine | 1 | 2010 | 158 | 0.080 |
Why?
| | Norepinephrine | 1 | 2010 | 201 | 0.080 |
Why?
| | Physical Exertion | 1 | 2010 | 205 | 0.070 |
Why?
| | Hypoglycemic Agents | 1 | 2018 | 1399 | 0.070 |
Why?
| | Exercise Test | 2 | 2026 | 630 | 0.070 |
Why?
| | Kidney | 1 | 2016 | 1496 | 0.070 |
Why?
| | Disease Progression | 1 | 2016 | 2865 | 0.070 |
Why?
| | Benzofurans | 1 | 2008 | 26 | 0.070 |
Why?
| | Prognosis | 1 | 2017 | 4329 | 0.070 |
Why?
| | Antioxidants | 1 | 2011 | 550 | 0.070 |
Why?
| | Cardiac Output | 2 | 2018 | 179 | 0.060 |
Why?
| | Lower Extremity | 1 | 2010 | 450 | 0.060 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2008 | 138 | 0.060 |
Why?
| | Liver X Receptors | 1 | 2025 | 29 | 0.060 |
Why?
| | Adipose Tissue, Brown | 1 | 2026 | 60 | 0.060 |
Why?
| | Biomarkers | 3 | 2012 | 4302 | 0.060 |
Why?
| | Phenylephrine | 2 | 2015 | 74 | 0.060 |
Why?
| | Middle Aged | 5 | 2025 | 36302 | 0.050 |
Why?
| | Signal Transduction | 2 | 2025 | 5223 | 0.050 |
Why?
| | Mitochondria, Heart | 1 | 2025 | 107 | 0.050 |
Why?
| | Cognition | 1 | 2013 | 1271 | 0.050 |
Why?
| | Erythrocytes | 1 | 2010 | 749 | 0.050 |
Why?
| | Dietary Supplements | 1 | 2008 | 584 | 0.050 |
Why?
| | Fibrosis | 1 | 2026 | 561 | 0.050 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2025 | 450 | 0.050 |
Why?
| | Athletes | 1 | 2026 | 425 | 0.050 |
Why?
| | Pregnancy | 3 | 2022 | 7215 | 0.040 |
Why?
| | Hypertension, Pulmonary | 2 | 2011 | 1957 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2025 | 729 | 0.040 |
Why?
| | Fluid Therapy | 2 | 2012 | 155 | 0.040 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2020 | 47 | 0.040 |
Why?
| | Aged | 2 | 2017 | 26215 | 0.040 |
Why?
| | Rats, Inbred WKY | 1 | 2019 | 35 | 0.040 |
Why?
| | Perfusion | 1 | 2020 | 251 | 0.040 |
Why?
| | Analysis of Variance | 2 | 2012 | 1300 | 0.040 |
Why?
| | Vasodilator Agents | 2 | 2011 | 330 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 3 | 2011 | 2525 | 0.030 |
Why?
| | Retrospective Studies | 1 | 2017 | 17325 | 0.030 |
Why?
| | Sheep | 1 | 2020 | 876 | 0.030 |
Why?
| | Infant, Premature | 1 | 2022 | 620 | 0.030 |
Why?
| | Muscles | 1 | 2018 | 330 | 0.030 |
Why?
| | Biological Transport, Active | 1 | 2016 | 69 | 0.030 |
Why?
| | Renal Veins | 1 | 2016 | 18 | 0.030 |
Why?
| | Renal Artery | 1 | 2016 | 43 | 0.030 |
Why?
| | Enzyme Inhibitors | 2 | 2011 | 821 | 0.030 |
Why?
| | Partial Pressure | 1 | 2015 | 30 | 0.030 |
Why?
| | Matched-Pair Analysis | 1 | 2015 | 37 | 0.030 |
Why?
| | Ion Channels | 1 | 2016 | 129 | 0.030 |
Why?
| | Respiration | 1 | 2015 | 207 | 0.030 |
Why?
| | Systole | 1 | 2015 | 181 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2017 | 318 | 0.030 |
Why?
| | Carbon Dioxide | 1 | 2015 | 227 | 0.030 |
Why?
| | Pulmonary Veins | 1 | 2014 | 108 | 0.020 |
Why?
| | Rabbits | 1 | 2014 | 653 | 0.020 |
Why?
| | Plasma Volume | 1 | 2012 | 20 | 0.020 |
Why?
| | Isotonic Solutions | 1 | 2012 | 42 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2018 | 935 | 0.020 |
Why?
| | Hematocrit | 1 | 2012 | 108 | 0.020 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2012 | 48 | 0.020 |
Why?
| | Glutathione Disulfide | 1 | 2011 | 30 | 0.020 |
Why?
| | Isoprostanes | 1 | 2011 | 15 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2017 | 2191 | 0.020 |
Why?
| | Echocardiography, Doppler, Pulsed | 1 | 2011 | 14 | 0.020 |
Why?
| | Texas | 1 | 2012 | 273 | 0.020 |
Why?
| | Drinking | 1 | 2011 | 44 | 0.020 |
Why?
| | Infusions, Intravenous | 1 | 2012 | 428 | 0.020 |
Why?
| | Monocrotaline | 1 | 2011 | 31 | 0.020 |
Why?
| | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2011 | 28 | 0.020 |
Why?
| | Rotation | 1 | 2011 | 121 | 0.020 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2011 | 49 | 0.020 |
Why?
| | Nitroprusside | 1 | 2011 | 71 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2016 | 910 | 0.020 |
Why?
| | Memory, Short-Term | 1 | 2013 | 269 | 0.020 |
Why?
| | Torque | 1 | 2010 | 82 | 0.020 |
Why?
| | Elastic Modulus | 1 | 2010 | 121 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2022 | 6464 | 0.020 |
Why?
| | Glutathione | 1 | 2011 | 370 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2011 | 308 | 0.020 |
Why?
| | Hyperoxia | 1 | 2010 | 107 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 3170 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2025 | 3937 | 0.020 |
Why?
| | Cytochrome P-450 Enzyme Inhibitors | 1 | 2008 | 13 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2008 | 88 | 0.020 |
Why?
| | Inhibitory Concentration 50 | 1 | 2008 | 91 | 0.020 |
Why?
| | Microsomes, Liver | 1 | 2008 | 85 | 0.020 |
Why?
| | Contrast Media | 1 | 2011 | 497 | 0.020 |
Why?
| | Propranolol | 1 | 2007 | 44 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2011 | 860 | 0.020 |
Why?
| | Arterioles | 1 | 2007 | 52 | 0.020 |
Why?
| | Body Weight | 1 | 2011 | 972 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2008 | 387 | 0.020 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2008 | 162 | 0.020 |
Why?
| | Iopamidol | 1 | 2006 | 12 | 0.020 |
Why?
| | Exercise Therapy | 1 | 2011 | 475 | 0.020 |
Why?
| | Drug Interactions | 1 | 2008 | 405 | 0.020 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2007 | 252 | 0.010 |
Why?
| | Blood Vessels | 1 | 2006 | 167 | 0.010 |
Why?
| | Liver Diseases | 1 | 2008 | 305 | 0.010 |
Why?
| | Mutation | 1 | 2016 | 4090 | 0.010 |
Why?
| | Kinetics | 1 | 2008 | 1568 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2012 | 3416 | 0.010 |
Why?
| | Models, Molecular | 1 | 2008 | 1599 | 0.010 |
Why?
| | Protein Binding | 1 | 2008 | 2240 | 0.010 |
Why?
| | Research Design | 1 | 2007 | 1139 | 0.010 |
Why?
| | Risk Factors | 1 | 2008 | 10917 | 0.010 |
Why?
|
|
Pearson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|